Editorial: Ulcerative Colitis Management in the Biologic Era-Data From the English Healthcare Databases
- PMID: 40936160
- DOI: 10.1111/apt.70346
Editorial: Ulcerative Colitis Management in the Biologic Era-Data From the English Healthcare Databases
References
-
- T. Raine, S. Bonovas, J. Burisch, et al., “ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment,” Journal of Crohn's & Colitis 16 (2022): 2–17.
-
- A. D. Frolkis, J. Dykeman, M. E. Negrón, et al., “Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta‐Analysis of Population‐Based Studies,” Gastroenterology 145 (2013): 996–1006.
-
- M. Berlet, K. Cira, A. Jell, et al., “Trends in Surgical Treatment for Ulcerative Colitis in the Era of Biologics—A Population‐Based Study Using German Diagnosis‐Related Groups Data,” Surgery 185 (2025): 109511.
-
- J. Couch, K. Thomas, T. R. Card, and D. J. Humes, “Temporal Trends in Medical and Surgical Management of Ulcerative Colitis in England: 2003‐2020,” Alimentary Pharmacology & Therapeutics (2025): 1–13, https://doi.org/10.1111/apt.70319.
-
- C. N. Bernstein, S. C. Ng, P. L. Lakatos, B. Moum, E. V. Loftus, Jr., and Epidemiology and Natural History Task Force of the International Organization of the Study of Inflammatory Bowel Disease, “A Review of Mortality and Surgery in Ulcerative Colitis: Milestones of the Seriousness of the Disease,” Inflammatory Bowel Diseases 19 (2013): 2001–2010.
Publication types
LinkOut - more resources
Full Text Sources